Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
IndexS&P 500 P/E54.58 EPS (ttm)1.32 Insider Own0.30% Shs Outstand1.76B Perf Week-1.03%
Market Cap126.82B Forward P/E22.48 EPS next Y3.20 Insider Trans-6.78% Shs Float1.74B Perf Month5.72%
Income2.33B PEG4.76 EPS next Q0.81 Inst Own74.90% Short Float0.84% Perf Quarter11.45%
Sales30.40B P/S4.17 EPS this Y44.60% Inst Trans0.29% Short Ratio2.33 Perf Half Y15.99%
Book/sh17.45 P/B4.13 EPS next Y11.02% ROA1.20% Target Price78.94 Perf Year29.71%
Cash/sh4.29 P/C16.80 EPS next 5Y11.47% ROE2.90% 52W Range54.32 - 74.15 Perf YTD26.23%
Dividend1.12 P/FCF42.85 EPS past 5Y47.40% ROI2.20% 52W High-2.85% Beta1.41
Dividend %1.55% Quick Ratio1.10 Sales past 5Y7.50% Gross Margin58.00% 52W Low32.62% ATR1.79
Employees99000 Current Ratio1.40 Sales Q/Q12.10% Oper. Margin10.20% RSI (14)59.19 Volatility3.09% 2.42%
OptionableYes Debt/Eq0.77 EPS Q/Q4.00% Profit Margin2.90% Rel Volume1.51 Prev Close70.73
ShortableYes LT Debt/Eq0.63 EarningsOct 17 BMO Payout220.30% Avg Volume6.30M Price72.04
Recom1.80 SMA203.61% SMA503.21% SMA20013.00% Volume9,522,927 Change1.85%
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Apr-20-17Reiterated Barclays Overweight $50 → $52
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Nov-16-18 05:17PM  Stanley Druckenmiller Sells Facebook, Buys PayPal in 3rd Quarter GuruFocus.com
09:30AM  Abbott (ABT) Up 3.8% Since Last Earnings Report: Can It Continue? Zacks
Nov-15-18 09:00AM  New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant PR Newswire
Nov-14-18 05:45PM  Abbott (ABT) Stock Moves -0.12%: What You Should Know Zacks
09:00AM  Abbott Recommends Rejection of Below-Market Mini-Tender Offer by Baker Mills LLC PR Newswire
Nov-12-18 05:11PM  Chartmaster says amid the market sell-off these are the b... CNBC Videos
03:44PM  Abbott Labs Falls 3% Investing.com
09:22AM  Surmodics' (SRDX) Q4 Earnings and Revenues Beat Estimates Zacks
Nov-09-18 05:37PM  Yacktman Asset Management Buys 4 Companies in 3rd Quarter GuruFocus.com
12:12PM  FOCUS-U.S. regulators snip red tape for medical devices to curb opioid crisis Reuters
01:00AM  FOCUS-U.S. regulators snip red tape for medical devices to curb opioid crisis Reuters
Nov-08-18 05:45PM  Abbott (ABT) Gains As Market Dips: What You Should Know Zacks
Nov-07-18 06:14PM  Cramer's advice on investing during Washington gridlock: Buy fast growers CNBC
12:22PM  Drug Stocks Climb as Investors Digest Midterm Election Results TheStreet.com
Nov-02-18 03:05PM  5 Income Stocks for Massive Payouts and Steady Growth InvestorPlace
07:30AM  Abbott (ABT) Q3 Earnings Top Estimates Zacks
Nov-01-18 12:09AM  [$$] Australia to move child refugees from island camps Financial Times
Oct-31-18 05:45PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
Oct-29-18 07:00PM  Another Kleiner investor has just raised her own fund TechCrunch
Oct-26-18 07:54PM  Abbott, AbbVie settle TriCor marketing case for $25 million Reuters
05:16PM  Abbott, AbbVie settle TriCor marketing case for $25 mln Reuters
02:56PM  Abbott, AbbVie settle U.S. case over TriCor marketing for $25 mln Reuters
02:48PM  How Does Abbott Laboratories (NYSE:ABT) Fare As A Dividend Stock? Simply Wall St.
07:45AM  Consolidated Research: 2018 Summary Expectations for Kulicke and Soffa Industries, QUALCOMM, Net Element, AT&T, Abbott Laboratories, and The Kroger Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-25-18 05:45PM  Abbott (ABT) Gains But Lags Market: What You Should Know Zacks
09:00AM  Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results PR Newswire
Oct-24-18 10:51AM  These 10 companies are helping employees pay off their student loans CNBC
Oct-23-18 11:37AM  Stocks to Buy, Stocks to Dump in This Volatile Market TheStreet.com
Oct-19-18 09:00AM  Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant PR Newswire
Oct-18-18 04:20PM  Abbott Labs Falls 3% Investing.com
12:28PM  Abbott Labs Declines on 3rd-Quarter Earnings GuruFocus.com
11:35AM  4 MedTech Names to Buy on 'Strong Fundamentals' Investopedia
05:00AM  [$$] Australia PM faces test in crucial Sydney by-election Financial Times
Oct-17-18 09:42PM  Edited Transcript of ABT earnings conference call or presentation 17-Oct-18 1:00pm GMT Thomson Reuters StreetEvents
04:11PM  Dow Slips for Fifth Day in Seven, Led Lower by IBM, Home Depot TheStreet.com
03:56PM  5 Top Stock Trades for Thursday InvestorPlace
02:51PM  Abbott (ABT) Q3 Earnings Top Estimates, Guidance Narrowed Zacks
01:08PM  Abbott Laboratories (ABT) Q3 2018 Earnings Conference Call Transcript Motley Fool
12:44PM  New Study Shows Abbott's Novel Diagnostic Test has the Potential to Demonstrate Gold Standard Accuracy and Speed, Which Could Help Rule Out Heart Attacks Earlier at the Point of Care PR Newswire
11:57AM  Barclays Takes Action on Health Care Stocks GuruFocus.com
10:57AM  ABT Stock Dips Following Q3 Earnings Results InvestorPlace
10:54AM  Abbott Labs Earnings, Revenue beat in Q3 Investing.com
10:39AM  Earnings & Economic Data Deluge Zacks
10:26AM  Q3 Earnings Stay (Mostly) Strong, Plus Housing Data Zacks
09:51AM  Stocks- U.S. Futures Fall as Investors Look Ahead to Fed Minutes Investing.com
09:36AM  Abbott Laboratories Posts Solid Q3 Earnings, Trims Full-Year Forecast TheStreet.com
09:08AM  Buy MedTech names due to improving fundamentals, Barclays says in sector initiation CNBC
09:05AM  Abbott (ABT) Q3 Earnings Top Estimates Zacks
08:19AM  Abbott: 3Q Earnings Snapshot Associated Press
08:17AM  [$$] Abbott Laboratories Meets Views, Narrows Outlook The Wall Street Journal
08:00AM  Abbott drops 2.3% premarket after in-line Q3 profit, narrowed 2018 outlook MarketWatch
07:52AM  Abbott Labs quarterly profit falls 6.6 pct on tax expense Reuters
07:45AM  Abbott Reports Third-Quarter 2018 Results PR Newswire
04:32AM  Dow set for 100 point-plus decline as volatile trading continues, but Netflix will boost Nasdaq CNBC
Oct-16-18 04:46PM  5 Earnings Charts in the Spotlight Zacks
02:30PM  Abbott Laboratories Q3 Earnings Preview Benzinga
01:23PM  Barclays says to buy this name in medical tech CNBC Videos
12:11PM  Can Abbott's (ABT) Steady Overall Growth Aid Q3 Earnings? Zacks
07:00AM  [$$] The Strategies AbbVie Employed to Protect Humira From Copycats The Wall Street Journal
Oct-15-18 03:00PM  Sell Abbott Laboratories Down to a 'Sleeping Position' TheStreet.com
08:57AM  Why Abbott Laboratories (ABT) Might Surprise This Earnings Season Zacks
08:30AM  Abbott Names Robert B. Ford President, Chief Operating Officer PR Newswire
Oct-12-18 06:11PM  Cramer's game plan: Increased volatility could turn positive with help from Trump, Fed CNBC
05:45PM  Abbott (ABT) Gains But Lags Market: What You Should Know Zacks
Oct-10-18 10:30AM  Abbott (ABT) Q3 Earnings Preview: How Are Events Shaping Up? Zacks
Oct-08-18 11:37AM  Top Stock Reports for Apple, Microsoft & Pfizer Zacks
Oct-05-18 03:40PM  The 7 Best Long-Term Stocks for Risk-Off Investors InvestorPlace
Oct-04-18 10:57AM  Health-Care Stocks High Valuations May Not Be a Problem Barrons.com
08:00AM  iPhone App for Abbott's FreeStyle Libre Flash Glucose Monitoring System Makes Diabetes Management Easier and More Convenient for Canadians CNW Group
Oct-03-18 07:47PM  [$$] Companies Lure New Workers With College Coaching, Student Debt Repayment The Wall Street Journal
10:35AM  Abbott's CE Mark for FreeStyle Libre 2 Boosts Diabetes Arm Zacks
Oct-02-18 06:01AM  3 Medical-Device Stocks at All-Time Highs -- Are They Buys? Motley Fool
Oct-01-18 08:00AM  Abbotts FreeStyle® Libre 2, with Optional Real-Time Alarms, Secures CE Mark for Use in Europe PR Newswire
Sep-28-18 02:55PM  How Did Abbott Laboratoriess (NYSE:ABT) 2.7% ROE Fare Against The Industry? Simply Wall St.
Sep-27-18 12:02PM  Abbott Labs' Test for Heart Attack Risk Granted With CE Mark GuruFocus.com
10:54AM  Abbott's Troponin-I Wins CE Mark, Vascular Arm Gets a Revamp Zacks
08:30AM  New Research Coverage Highlights CyberArk Software, Mercer International, American Airlines Group, Abbott Laboratories, Open Text, and The Kroger Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-26-18 06:01PM  Abbott Receives CE Mark for First Troponin Test to Help Predict the Chance of Heart Attack in Apparently Healthy Adults Potentially Months to Years in Advance PR Newswire
01:42PM  The trade on Abbott Labs, how oil will impact American Ai... CNBC Videos
Sep-25-18 02:45PM  One-Year Results from Real-World Study Showed Abbott's Portico Transcatheter Aortic Valve Safely and Successfully Reduced Severe Aortic Stenosis PR Newswire
11:43AM  5 Companies Hit 52-Week Highs GuruFocus.com
05:05AM  Bull of the Day: Penumbra (PEN) Zacks
Sep-24-18 03:15PM  Drug Stocks Rally Midday; Chinese Stocks Take a Hit Investing.com
12:34PM  Abbott Labs Rises 3.35% Investing.com
10:10AM  Why Abbott (ABT) is Poised to Beat Earnings Estimates Again Zacks
09:38AM  Stocks Slump As Trade War Intensifies; 3 Med Stocks Rally, Tilray Tumbles Investor's Business Daily
Sep-23-18 01:20PM  Landmark Study Shows Treatment with Abbott's MitraClip® is Superior to Medical Therapy for Advanced Heart Failure Patients with Significant Secondary Mitral Regurgitation PR Newswire
Sep-20-18 04:37PM  Abbott Banks on New Approvals and Buyouts, Competition Rife Zacks
01:54AM  [$$] Beto ORourke electrifies voters as he takes on Ted Cruz in Texas Financial Times
Sep-19-18 09:00AM  Abbott Hosts Conference Call for Third-Quarter Earnings PR Newswire
Sep-18-18 06:41PM  Medical - Products Stock Outlook: Short-Term Pain Inevitable Zacks
09:30AM  ABT or PETQ: Which Is the Better Value Stock Right Now? Zacks
09:08AM  Here's Why You Should Add Abbott (ABT) to Your Portfolio Now Zacks
08:29AM  Non-diabetics are using diabetes technology to track their blood sugar and improve their health MarketWatch
Sep-14-18 03:47PM  Abbott Labs Declares Quarterly Dividend GuruFocus.com
12:26PM  Abbott Ireland Financing DAC -- Moody's assigns Baa1 to Abbott Lab's proposed Euro notes offering Moody's
Sep-13-18 11:14AM  Abbott Declares 379th Consecutive Quarterly Dividend PR Newswire
10:58AM  Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI) PR Newswire
06:13AM  India bans 328 combination drugs in setback for pharma companies Reuters
Sep-12-18 02:57PM  5 Growth Stocks to Buy for Reliable Income in Retirement InvestorPlace
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; and anti-infective clarithromycin, as well as provides influenza vaccine and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; benchtop systems and rapid tests in the areas of infectious diseases; molecular point-of-care test systems for influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watkin JaredSenior Vice PresidentNov 02Option Exercise38.4065,0002,496,000128,640Nov 06 05:08 PM
Watkin JaredSenior Vice PresidentNov 02Sale71.0065,0004,615,00063,640Nov 06 05:08 PM
Bracken Sharon JSenior Vice PresidentSep 28Sale73.351,732127,04439,029Oct 02 06:58 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentSep 28Sale73.395,000366,95788,521Oct 02 06:58 PM
Blaser Brian JExecutive Vice PresidentSep 20Option Exercise27.4358,2001,596,165195,018Sep 21 05:02 PM
Blaser Brian JExecutive Vice PresidentSep 20Sale68.7958,2004,003,862136,818Sep 21 05:02 PM
Funck Robert ESenior Vice PresidentSep 05Option Exercise25.2436,400918,727145,080Sep 07 05:15 PM
Contreras JaimeSenior Vice PresidentAug 29Option Exercise37.67172,4686,496,984222,904Aug 31 05:04 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.8464,2684,295,39554,968Aug 31 05:05 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.7495,7936,393,590127,111Aug 31 05:04 PM
LANE ANDREW HExecutive Vice PresidentAug 29Sale67.119,097610,51326,583Aug 31 05:03 PM
Bracken Sharon JSenior Vice PresidentJul 30Sale65.1661540,07340,761Jul 31 05:01 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Option Exercise26.0264,9001,688,374363,200Jul 26 05:05 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Sale65.0064,9004,218,500298,300Jul 26 05:05 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 24Sale63.5080350,99178,417Jul 24 05:02 PM
Blaser Brian JExecutive Vice PresidentJul 24Sale63.9615,100965,789136,818Jul 26 05:09 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 23Sale63.2024715,61079,220Jul 24 05:02 PM
Bracken Sharon JSenior Vice PresidentJul 23Sale63.2025916,36941,376Jul 24 05:01 PM
Funck Robert ESenior Vice PresidentJun 05Option Exercise26.0212,800332,992117,293Jun 07 05:08 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 18Sale61.501,00061,50094,581May 21 05:16 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 17Sale61.052,000122,09295,581May 21 05:16 PM
Bracken Sharon JSenior Vice PresidentMay 04Sale58.562,150125,90942,140May 08 05:00 PM
Contreras JaimeSenior Vice PresidentApr 23Sale59.3684950,3972,595Apr 25 05:12 PM
BIRD ROGERSenior Vice PresidentMar 09Sale62.758,262518,45058,174Mar 13 05:03 PM
Watkin JaredSenior Vice PresidentMar 07Sale61.193,000183,57965,515Mar 09 05:01 PM
Bracken Sharon JSenior Vice PresidentMar 05Sale60.272,100126,55944,290Mar 07 05:11 PM
Fussell Stephen RExecutive Vice PresidentMar 01Sale60.1311,106667,804161,052Mar 02 05:17 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 01Sale58.9790553,36997,581Mar 02 05:15 PM
Watkin JaredSenior Vice PresidentMar 01Sale58.8799658,63568,515Mar 02 05:15 PM
MANNING JOSEPH JSenior Vice PresidentMar 01Sale58.981,43084,34438,466Mar 02 05:14 PM
Contreras JaimeSenior Vice PresidentMar 01Sale59.746,284375,38150,436Mar 02 05:13 PM
Funck Robert ESenior Vice PresidentMar 01Sale58.991,22071,970104,493Mar 02 05:11 PM
BIRD ROGERSenior Vice PresidentMar 01Sale58.801,64596,72866,436Mar 02 05:13 PM
Bracken Sharon JSenior Vice PresidentMar 01Sale58.931,05362,05646,390Mar 02 05:09 PM
STARKS DANIEL JDirectorFeb 27Buy60.7729,5541,795,9017,012,839Feb 28 06:35 PM
STARKS DANIEL JDirectorFeb 27Buy60.8740024,3487,013,239Feb 28 06:36 PM
STARKS DANIEL JDirectorFeb 27Buy60.6740,0372,429,2376,983,285Feb 28 06:34 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Option Exercise38.40104,6424,018,253289,526Feb 21 07:23 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.7342,7092,550,813190,416Feb 21 07:23 PM
Watkin JaredSenior Vice PresidentFeb 20Sale59.2929717,60973,377Feb 21 06:21 PM
PEDERSON MICHAEL JSenior Vice PresidentFeb 20Sale59.2945927,21382,069Feb 21 06:18 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.845,532331,048184,884Feb 21 07:24 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.6156,4013,361,948233,125Feb 21 07:23 PM
Blaser Brian JExecutive Vice PresidentJan 31Option Exercise22.3927,733620,995156,587Feb 01 05:50 PM
Blaser Brian JExecutive Vice PresidentJan 31Sale62.2627,7331,726,634128,854Feb 01 05:50 PM
Fussell Stephen RExecutive Vice PresidentJan 31Sale62.681,00062,680561,518Feb 01 05:48 PM
Ford Robert BExecutive Vice PresidentJan 30Option Exercise31.0583,4672,591,776135,633Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Option Exercise37.32388,98314,516,345571,121Feb 01 05:48 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.7729,0501,823,535153,288Feb 01 05:49 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.8413,313836,607139,975Feb 01 05:49 PM
Ford Robert BExecutive Vice PresidentJan 30Sale63.0340,8022,571,62452,166Feb 01 05:47 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.75226,41214,207,000343,709Feb 01 05:48 PM
Fussell Stephen RExecutive Vice PresidentJan 30Sale62.83161,37110,139,045182,338Feb 01 05:48 PM
Ford Robert BExecutive Vice PresidentJan 30Sale62.9842,6652,687,13492,968Feb 01 05:47 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentDec 14Option Exercise47.0028,3191,330,993102,117Dec 14 06:01 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentDec 14Sale54.9228,3191,555,26073,798Dec 14 06:01 PM
WHITE MILES DChairman and CEODec 06Option Exercise26.70530,00014,149,5693,677,913Dec 08 05:26 PM
WHITE MILES DChairman and CEODec 06Sale54.9410,644584,8273,148,022Dec 08 05:29 PM
WHITE MILES DChairman and CEODec 06Sale54.7049,2032,691,2243,230,087Dec 08 05:27 PM
WHITE MILES DChairman and CEODec 06Sale54.8371,5303,921,6403,158,557Dec 08 05:28 PM
WHITE MILES DChairman and CEODec 06Sale54.41276,88615,064,6933,401,027Dec 08 05:26 PM
WHITE MILES DChairman and CEODec 06Sale54.50121,7376,635,2153,279,290Dec 08 05:26 PM
Bracken Sharon JSenior Vice PresidentNov 30Sale56.122,188122,79525,018Dec 01 05:08 PM
Wellisch Alejandro DSenior Vice PresidentNov 22Sale55.862,153120,2708,803Nov 22 05:15 PM
open in yahoo | open in reuters | open in google